Johnson & Johnson is reportedly preparing to put its estimated $2.5-$3 billion global media account into review. If so, it could change the current landscape of the largest media buyers.

The pitch is slated for early next year, following the closing of J&J's acquisition of Pfizer's over-the-counter drug and personal-care business, writes AdAge (via MediaBuyerPlanner). One potential result could be a consolidation of the three main media roster shops - OMD Worldwide, Universal McCann, and Carat (the incumbent on the incoming Pfizer brands).

Other roster shops include Naked, which works on J&J's U.S. communications planning, Interpublic's ID Media, which handles direct TV buying, and WPP Group's Mediaedge:cia, which buys interactive media for the incoming Pfizer brands.

A consolidation of the account is not an unlikely result, considering that media savings is part of what made the $16.6 billion Pfizer acquisition attractive. In fact, the company is looking to "squeeze out every bit of savings they can," said one person familiar with the situation.

Overseeing the review are Brian Perkins, corporate VP-corporate affairs, and Kim Kadlec, VP-worldwide media. The two are thought to advocate greater use of nontraditional media. Johnson & Johnson's central marketing services team made headlines earlier in the year by pulling out of the traditional network TV upfront.